Completed
A Study to Evaluate the Pharmacokinetics of Margetuximab in Chinese Patients With HER2+ MBC
NCT04398108
- Conditions
- Breast Diseases, Breast Neoplasms, HER2 Positive Metastatic Breast Cancer, +4 more
- Locations
-
- The fifth medical center of the General Hospital of people's Liberation Army of China Beijing, Beijing Municipality, China
- The fourth hospital of Hebei Medical University Shijiazhuang, Hebei, China
- Henan Cancer Hospital Zhengzhou, Henan, China